The Digital Revolution: Enabling Automation in Cell Therapy Manufacturing
As emerging therapies move through the clinical pipeline, scale and regulatory compliance have come to the forefront of the discussion. A fully automated process that addresses digital connectivity and instrument-to-instrument compatibility can help overcome some of the current cell therapy manufacturing challenges, increase the quality of the final product, as well as reduce manufacturing failure rates.
Watch now to learn more about:
- The time and cost-saving advantages of implementing a fully automated manufacturing workflow
- The importance of digital connectivity solutions to ensure process and data integrity
- Considerations and benefits of a closed, modular cell therapy workflow
Speakers
Sean Chang, PhD
Manager, Early Innovation Cell and Gene Therapy
Bruce Greenwald
Bruce Greenwald, DeltaV Platform Business, Development Manager
Krishnendu Roy, PhD
The Robert. A. Milton Chair and Professor